Aviation Medication Transparency Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3258 Introduced in Senate (IS)]

<DOC>

119th CONGRESS
  1st Session
                                S. 3258

To require the Administrator of the Federal Aviation Administration to
publish the list of medications that the Administrator has compiled for
purposes of the medical certification of airmen and air traffic control
                  specialists, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           November 20, 2025

  Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, and Mrs. Britt)
introduced the following bill; which was read twice and referred to the
           Committee on Commerce, Science, and Transportation

_______________________________________________________________________

                                 A BILL

To require the Administrator of the Federal Aviation Administration to
publish the list of medications that the Administrator has compiled for
purposes of the medical certification of airmen and air traffic control
                  specialists, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Aviation Medication Transparency Act
of 2025''.

SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED MEDICATIONS.

    (a) Purpose.--The purpose of this Act is to ensure that aviation
stakeholders, including airmen, air traffic control specialists, and
individuals training to become airmen or air traffic control
specialists, who are applicants for medical certification are informed,
in a user-friendly and accessible manner, of the medications they may
be safely prescribed.
    (b) In General.--Not later than 1 year after the date of enactment
of this Act, the Administrator of the Federal Aviation Administration
(in this section referred to as the ``Administrator'') shall publish
and maintain on a publicly available website of the Federal Aviation
Administration (in this section referred to as the ``FAA'') a list of
medications that the Administrator, as of the date of publication,
has--
            (1) determined may be safely prescribed to an applicant for
        medical certification to treat certain medical conditions; and
            (2) approved for purposes of the issuance of a medical
        certification to an airman or air traffic control specialist.
    (c) Requirements.--To ensure medical appropriateness, user-
friendliness, and appropriate dissemination, the list required under
subsection (b) shall--
            (1) be drafted in consultation with--
                    (A) the Aeromedical Innovation and Modernization
                Working Group (established under section 411(a) of the
                FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note))
                (in this section referred to as the ``Working Group'');
                    (B) institutions of higher education that are
                accredited by the Aviation Accreditation Board
                International;
                    (C) the certified exclusive bargaining
                representatives of air traffic controllers of the FAA
                certified under section 7111 of title 5, United States
                Code;
                    (D) organizations representing certified collective
                bargaining representative of airline pilots; and
                    (E) any other stakeholder determined relevant by
                the Working Group;
            (2) cover all medications approved by the Administrator,
        including prescription medications and over-the-counter
        medications;
            (3) be drafted in a user-friendly and accessible manner and
        provided to airmen, air traffic control specialists, and
        individuals training to become airmen or air traffic control
        specialists at the time when any such individual first seeks a
        medical certification;
            (4) if applicable, indicate the minimum and average period
        of time an airman or air traffic control specialist is required
        to have limited or no duties to stabilize on an approved
        medication;
            (5) include the list of medications that the Administrator
        has designated as ``Do Not Issue'';
            (6) include information for doctors or medical providers to
        contact the FAA regarding questions related to such list,
        including through a new or existing mechanism that is
        accessible to such doctors and medical providers;
            (7) include any additional information that the
        Administrator determines is appropriate to provide with respect
        to what conditions a certain medication may or may not be used
        to treat, as well as any information to explain why a
        medication is allowed or prohibited by the FAA; and
            (8) include any other information or clarification that the
        Administrator determines appropriate.
    (d) Annual Update.--Not later than 1 year after the date of
publication of the list required under subsection (b), and annually
thereafter, the Administrator shall update such list, as appropriate.
                                 <all>